Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1013 studies found for:    Huntington's Disease
Show Display Options
RSS Create an RSS feed from your search for:
Huntington's Disease
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed A Study of the Novel Drug Dimebon in Patients With Huntington's Disease
Condition: Huntington's Disease
Interventions: Other: Placebo;   Drug: Dimebon
2 Unknown  Study of Huntington Patients in Connection With European Huntington's Disease Network (EHDN)
Condition: Huntington Disease
Intervention:
3 Active, not recruiting Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease
Condition: Huntington Disease
Intervention: Drug: pridopidine
4 Completed A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Versus Placebo for Symptomatic Treatment in Patients With Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: Pridopidine;   Other: Placebo
5 Completed A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease
Condition: Huntington's Disease
Intervention: Drug: SEN0014196
6 Completed An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196
Condition: Huntington Disease
Interventions: Drug: SEN0014196 (Low Dose);   Drug: SEN0014196 (High Dose);   Drug: Placebo
7 Terminated Efficacy, Safety and Tolerability of AFQ056 in Patients With Huntington's Disease in Reducing Chorea
Conditions: Huntington's Disease;   Chorea
Interventions: Drug: AFQ056;   Drug: Placebo
8 Recruiting Study of Biomarkers That Predict the Evolution of Huntington's Disease
Condition: Huntington Disease
Interventions: Other: Huntington patient evaluation;   Other: Healthy subject evaluation
9 Completed Family Health After Predictive Huntington Disease (HD) Testing
Condition: Huntington Disease
Intervention: Genetic: Mutation in the gene
10 Completed Caregiver Burden in Huntington's Disease
Condition: Caregiver of Huntington's Disease Patient
Intervention: Other: ZARIT Burden Interview
11 Recruiting Exercise Effects in Huntington's Disease
Condition: Huntington's Disease
Intervention: Behavioral: Exercise training
12 Completed Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease
Condition: Huntington's Disease
Intervention: Drug: Dimebon
13 Completed A Study of Treatment With Pridopidine (ACR16) in Patients With Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: ACR16;   Drug: Placebo
14 Completed A Study of Pridopidine (ACR16) for the Treatment of Patients With Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: ACR16 10 mg;   Drug: ACR16 22.5 mg;   Drug: ACR16 45 mg;   Other: Placebo
15 Not yet recruiting PINS Stimulator System for Deep Brain Stimulation in Huntington's Disease
Condition: Huntington's Disease
Intervention: Device: Deep Brain Stimulation
16 Active, not recruiting Neurobiological Predictors of Huntington's Disease (PREDICT-HD)
Condition: Huntington Disease
Intervention:
17 Completed Neuroprotection by Cannabinoids in Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD);   Drug: Placebo
18 Completed
Has Results
Pilot Study of Minocycline in Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: minocycline;   Drug: Matching placebo
19 Completed TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease
Condition: Huntington Disease
Intervention: Drug: Ethyl-EPA (Miraxion™)
20 Completed Creatine Therapy for Huntington's Disease
Condition: Huntington's Disease
Intervention: Drug: Creatine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.